A Phase Ib/II Study of AK112 in Combination With AK117 in Advanced Malignant Tumors
- Conditions
- Interventions
- First Posted Date
- 2022-02-08
- Last Posted Date
- 2022-05-11
- Lead Sponsor
- Akeso
- Target Recruit Count
- 114
- Registration Number
- NCT05229497
- Locations
- 🇨🇳
Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China
A Study of AK117/AK112 in Metastatic Triple-Negative Breast Cancer
- Conditions
- Interventions
- First Posted Date
- 2022-02-07
- Last Posted Date
- 2022-09-10
- Lead Sponsor
- Akeso
- Target Recruit Count
- 80
- Registration Number
- NCT05227664
- Locations
- 🇨🇳
Hunan Cancer Hospital, Changsha, China
🇨🇳Xiangyang Central Hospital, Xiangyang, China
AK104 in Neoadjuvant Treatment of Cervical Cancer
- First Posted Date
- 2022-02-07
- Last Posted Date
- 2024-11-01
- Lead Sponsor
- Akeso
- Target Recruit Count
- 14
- Registration Number
- NCT05227651
- Locations
- 🇨🇳
Zhejiang Cancer Hospital, Hanzhong, Zhejiang, China
A Phase II Trial of AK104 in Advanced Non-Small Cell Lung Cancer
- First Posted Date
- 2022-01-31
- Last Posted Date
- 2022-04-01
- Lead Sponsor
- Akeso
- Target Recruit Count
- 40
- Registration Number
- NCT05215067
- Locations
- 🇨🇳
Jiangsu Cancer Hospital, Nanjing, Jiangsu, China
A Study of AK112 in Advanced Malignant Tumors
- Conditions
- Interventions
- First Posted Date
- 2022-01-28
- Last Posted Date
- 2024-02-21
- Lead Sponsor
- Akeso
- Target Recruit Count
- 250
- Registration Number
- NCT05214482
- Locations
- 🇨🇳
Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China
A Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK114
- First Posted Date
- 2022-01-20
- Last Posted Date
- 2022-01-20
- Lead Sponsor
- Akeso
- Target Recruit Count
- 30
- Registration Number
- NCT05200273
- Locations
- 🇦🇺
Ashford Cancer Centre, Kurralta Park, South Australia, Australia
Phase 3 Clinical Study of AK112 for NSCLC Patients
- Conditions
- Interventions
- First Posted Date
- 2022-01-11
- Last Posted Date
- 2024-06-28
- Lead Sponsor
- Akeso
- Target Recruit Count
- 322
- Registration Number
- NCT05184712
- Locations
- 🇨🇳
Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
Study of AK119 in Subjects With Advanced Solid Tumors
- First Posted Date
- 2021-12-30
- Last Posted Date
- 2024-04-25
- Lead Sponsor
- Akeso
- Target Recruit Count
- 16
- Registration Number
- NCT05173792
- Locations
- 🇨🇳
Fudan University Zhongshan Hospital, Shanghai, China
🇨🇳Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
A Study to Evaluate the Efficacy and Safety of AK120 in the Treatment of Subjects With Moderate-to-severe Asthma
- First Posted Date
- 2021-12-13
- Last Posted Date
- 2022-10-12
- Lead Sponsor
- Akeso
- Target Recruit Count
- 1
- Registration Number
- NCT05155020
- Locations
- 🇨🇳
Inner Mongolia People's Hospital, Hohhot, Inner Mongolia, China
🇨🇳The Second Hospital of Anhui Medical University, Hefei, Anhui, China
🇨🇳Beijing Jingmei General Hospital, Beijing, Beijing, China
A Study of AK109 Combined With AK104 in Patients With Advanced Solid Tumors
- First Posted Date
- 2021-12-02
- Last Posted Date
- 2024-04-25
- Lead Sponsor
- Akeso
- Target Recruit Count
- 198
- Registration Number
- NCT05142423
- Locations
- 🇨🇳
First affliated hospital of Zhejiang University, Hangzhou, Zhejiang, China